Sana Biotechnology Inc (SANA)

Finanzdaten der Sana Biotechnology Inc-Aktie (SANA)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	4,055% 90.62	2.181	116.29	84.05	-
Operating Income/Loss	4,055% -90.62	-2.181	-116.29	-84.05	-81.79
Income/Loss From Continuing Operations Before Tax	9,055% -88.12	0.984	-114.00	-82.12	-80.44
Income/Loss From Continuing Operations After Tax	9,055% -88.12	0.984	-114.00	-82.12	-80.44
Net Income/Loss	9,055% -88.12	0.984	-114.00	-82.12	-80.44
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.52% 0.936	196.98	192.54	191.23	0.699
Diluted Average Shares	99.53% 0.936	200.47	192.54	191.23	0.699
Basic Earnings Per Share	-0.45	-	-0.59	-0.43	-0.42
Diluted Earnings Per Share	-0.45	-	-0.59	-0.43	-0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-